Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prophylaxis of Post-ERCP Acute Pancreatitis: a Randomized, Multicenter, Open-label Study Comparing Indomethacin Versus Indomethacin-ringer Lactate Combination

NCT05381428 is registered in ClinicalTrials.gov with Azienda USL Reggio Emilia - IRCCS as lead sponsor.

NCT NCT05381428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05381428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prophylaxis of Post-ERCP Acute Pancreatitis: a Randomized, Multicenter, Open-label Study Comparing Indomethacin Versus Indomethacin-ringer Lactate Combination
Lead sponsor
Azienda USL Reggio Emilia - IRCCS
Phase
Phase 3
Overall status
Completed
Start date
May 13, 2022
Completion date
October 12, 2024
Enrollment
184 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatitis, acute